ISSN 1016-5169 | E-ISSN 1308-4488
pdf
A retrospective analysis of our paclitaxel-eluting stent (Genius TAXCOR I) implantations and follow-up results [Turk Kardiyol Dern Ars]
Turk Kardiyol Dern Ars. 2011; 39(8): 675-682 | DOI: 10.5543/tkda.2011.01318

A retrospective analysis of our paclitaxel-eluting stent (Genius TAXCOR I) implantations and follow-up results

Giray Kabakçı, Uğur Canpolat, Ahmet Hakan Ateş, Hikmet Yorgun, Hamza Sunman, Ergün Barış Kaya, Muhammed Dural, Kudret Aytemir, Lale Tokgözoğlu, Ali Oto
Hacettepe University Faculty of Medicine, Department of Cardiology, Ankara, Turkey


OBJECTIVES
We evaluated our paclitaxel-eluting stent (Genius TAXCOR I) implantations and follow-up results in patients with coronary artery disease.

STUDY DESIGN
The study included 101 patients (75 men, 26 women; mean age 60±10 years) who underwent elective paclitaxel-eluting stent deployment for de novo native coronary artery lesions. Sixteen patients received two stents. Lesion types were as follows: type A (23.9%), type B1 (29.1%), type B2 (32.5%), and type C (14.5%). Twelve lesions (10.3%) exhibited mild tortuosity, 32 (27.4%) had mild calcification, 12 had (10.3%) an angulation of more than 45 degrees, while eight (7.7%) had thrombus. Following stent implantation, the patients were examined at 1, 6, and 12 months, and annually thereafter. The mean follow-up period was 48.9±5.7 months (range 35 to 60 months).

RESULTS
Stent implantation was successful in all the patients. The mean diameter stenosis was 82.8±9.9%, the mean stent diameter was 3.1±0.6 mm, and the mean stent length was 16.0±5.2 mm. During the follow-up period, 46 patients (45.5%) required coronary angiography, of which eight (17.4%) received target vessel revascularization, and four (8.7%) received target lesion revascularization. One patient (1.0%) died from sudden cardiac death.

CONCLUSION
The clinical and angiographic follow-up results of this study involving relatively low- and intermediate-risk patients indicate that the use of the Genius TAXCOR I stents is effective and beneficial for the prevention of stent thrombosis and restenosis.

Keywords: Coronary angiography, coronary artery disease, coronary restenosis, paclitaxel; stents

How to cite this article
Giray Kabakçı, Uğur Canpolat, Ahmet Hakan Ateş, Hikmet Yorgun, Hamza Sunman, Ergün Barış Kaya, Muhammed Dural, Kudret Aytemir, Lale Tokgözoğlu, Ali Oto. A retrospective analysis of our paclitaxel-eluting stent (Genius TAXCOR I) implantations and follow-up results. Turk Kardiyol Dern Ars. 2011; 39(8): 675-682

Corresponding Author: Uğur Canpolat, Türkiye
Manuscript Language: Turkish


Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper:
0.22
SCImago Journal Rank: 0.348

Quick Search



Copyright © 2024 Archives of the Turkish Society of Cardiology



Kare Publishing is a subsidiary of Kare Media.